Methotrexate Cutaneous Toxicity following a Single Dose of 10 mg in a Case of Chronic Plaque Psoriasis: A Possible Idiosyncratic Reaction
- PMID: 30258802
- PMCID: PMC6137652
- DOI: 10.4103/idoj.IDOJ_316_17
Methotrexate Cutaneous Toxicity following a Single Dose of 10 mg in a Case of Chronic Plaque Psoriasis: A Possible Idiosyncratic Reaction
Abstract
Low-dose methotrexate is a well-tolerated and inexpensive systemic immunosuppressive agent used commonly in dermatology. However, several adverse events such as pancytopenia, pneumonitis, mucositis, and cutaneous ulcerations may develop during acute toxicity with dose-dependent or idiosyncratic mechanisms. Risk factors for methotrexate toxicity include advanced age, hypoalbuminemia, renal dysfunction, and concomitant drugs increasing the level of methotrexate in the body. We present a case of methotrexate toxicity presenting with classical features along with mucocutaneous side-effects, such as ulceration of psoriatic plaques and acral erythema, following a single dose of methotrexate.
Keywords: Cutaneous ulceration; low-dose methotrexate; methotrexate toxicity.
Conflict of interest statement
There are no conflicts of interest.
Figures



Similar articles
-
Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.Dermatol Online J. 2011 Nov 15;17(11):2. Dermatol Online J. 2011. PMID: 22136858
-
[Apparent worsening of psoriasis lesions revealing methotrexate overdosage].Ann Dermatol Venereol. 2018 Feb;145(2):104-108. doi: 10.1016/j.annder.2017.07.004. Epub 2017 Sep 13. Ann Dermatol Venereol. 2018. PMID: 28917574 French.
-
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.Am J Clin Dermatol. 2022 Jul;23(4):449-457. doi: 10.1007/s40257-022-00692-1. Epub 2022 Apr 29. Am J Clin Dermatol. 2022. PMID: 35486323
-
Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.Dermatol Ther (Heidelb). 2014 Dec;4(2):145-56. doi: 10.1007/s13555-014-0056-z. Epub 2014 Jun 19. Dermatol Ther (Heidelb). 2014. PMID: 24942326 Free PMC article.
-
Fatal low-dose methotrexate toxicity: A case report and literature review.Dermatol Ther. 2022 Dec;35(12):e15945. doi: 10.1111/dth.15945. Epub 2022 Nov 14. Dermatol Ther. 2022. PMID: 36259229 Review.
Cited by
-
Protective mechanisms of icariin in methotrexate-induced renal damage: role of Nrf2/HO-1 and apoptosis reduction.J Complement Integr Med. 2025 Feb 20;22(2):335-342. doi: 10.1515/jcim-2024-0431. eCollection 2025 Jun 1. J Complement Integr Med. 2025. PMID: 39970335
References
-
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. - PubMed
-
- The use of the WHO-UMC system for standardised case causality assessment. [Last accessed on 2018 Jan 29]. Available from: http://www.WHO-UMC.org/graphics/4409.pdf .
-
- Agarwal V, Chauhan S, Singh R, Sachdev A, D'Cruz S, Tahlan A. Pancytopenia with the first dose of methotrexate in a patient with psoriatic arthritis. J Indian Rheumatol Assoc. 2005;13:60–1.